Keywords: Pharmaceutical industry


OpenAI Acquires Orchestra Bio to Accelerate AI-Powered Drug Development

OpenAI is expanding its ambitions in biotechnology with the acquisition of Orchestra Bio, a startup developing artificial intelligence tools to help pharmaceutical and biotechnology companies coordinate drug development. Announced on October 20, 2026, the deal brings new expertise and technology into......

Morocco strengthens national control of vaccine manufacturing platform as Mohammed VI Investment Fund acquires Recipharm stake

Morocco is entering a new phase in its strategy to build domestic vaccine and biological-product manufacturing capabilities, with the Mohammed VI Investment Fund set to acquire Recipharm’s 10% stake in Maroc Biotechnologies (MARBIO). The transaction follows a framework agreement signed on September......

Bayer commits $2.2 billion to new pharmaceutical plant in Ohio

German pharmaceutical and life sciences group Bayer is set to invest $2.2 billion in a new pharmaceutical manufacturing facility in New Albany, Ohio, strengthening its production capacity in the United States as Washington pushes drugmakers to increase domestic manufacturing. The project represents......

Lamia Tazi rises to 22nd in Forbes Middle East healthcare leaders ranking

Moroccan pharmaceutical executive Lamia Tazi has moved up to 22nd place in Forbes Middle East’s 2026 ranking of the region’s Top Healthcare Leaders, strengthening her position among prominent figures in the Middle East and North Africa’s healthcare industry. Tazi, who serves as CEO......

Morocco’s Industrial Production Drops 4.5% as Automotive and Pharma Grow

Morocco’s manufacturing sector experienced a significant contraction in the second quarter of 2026, with overall output declining by 4.5% year on year, according to data released by the High Commission for Planning (HCP) on September 16. The figures, which exclude petroleum refining, point to......

Study warns US drug policies could cost Swiss pharmaceutical industry billions

New research commissioned by Swiss pharmaceutical industry association Interpharma warns that changes in U.S. drug-pricing policies could have serious consequences for Switzerland’s economy, pharmaceutical sector and patients. The study, conducted by research firm BAK Economics, estimates that......

GSK to close 115-year-old vaccine plant in Dresden

Dresden is facing the loss of one of its historic industrial sites after pharmaceutical giant GlaxoSmithKline (GSK) announced plans to close its vaccine manufacturing facility in the German city by summer 2028. The decision puts around 650 jobs at risk and marks a major setback for a site with more......

WHO strengthens partnership with Côte d’Ivoire to support health system transformation

The World Health Organization (WHO) is seeking to deepen its cooperation with Côte d’Ivoire as the West African country continues reforms aimed at modernizing its healthcare system and improving access to essential medical services. Following a working visit to Abidjan, WHO Director-General......

GSK beats second-quarter expectations with strong earnings and $2.52 billion efficiency plan

GSK delivered stronger-than-expected second-quarter earnings on Tuesday while unveiling a major multi-year cost-saving initiative aimed at accelerating investment in its medicines pipeline and supporting long-term revenue growth. The British pharmaceutical company announced a £1.9 billion ($2.52......